UHT (Universal Health Realtyome Trust) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


UHT Universal Health Realty Income Trust UHT
75 GF Score
Price $41.24
GF Value $40.74
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Universal Health Realtyome Trust Research & Development?

Universal Health Realtyome Trust UHT +3.15% 75 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates UHT with a GF Score™ of 75/100 and a GF Value™ of $40.74 (Fairly Valued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Universal Health Realtyome Trust's Research & Development for the three months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Universal Health Realtyome Trust  (NYSE:UHT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Universal Health Realtyome Trust Research & Development Related Terms

Universal Health Realtyome Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Universal Health Realtyome Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Health Realtyome Trust Research & Development Chart

Universal Health Realtyome Trust Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Universal Health Realtyome Trust Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
UHT
75GF Score
Universal Health Realty Income Trust UHT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universal Health Realtyome Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Universal Health Realtyome Trust (UHT) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Universal Health Realtyome Trust and its competitors.
Is Universal Health Realtyome Trust's Research & Development too high?
Universal Health Realtyome Trust's current Research & Development is $0.00 Mil. Overall, Universal Health Realtyome Trust has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Universal Health Realtyome Trust's Research & Development compare to NHP and CHCT?
Universal Health Realtyome Trust's Research & Development of $0.00 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Universal Health Realtyome Trust and its competitors. Universal Health Realtyome Trust's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Health Realtyome Trust stock overvalued right now?
Based on GuruFocus' analysis, Universal Health Realtyome Trust (UHT) is currently considered Fairly Valued. The stock's GF Value™ is $40.74, compared to a current price of $41.24 — trading 1.2% above its estimated fair value. The current Research & Development is $0.00 Mil. Universal Health Realtyome Trust's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Universal Health Realtyome Trust (UHT), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universal Health Realtyome Trust (UHT) Overvalued in 2026?

Based on GuruFocus' analysis, Universal Health Realtyome Trust stock appears to be overvalued. The current stock price of $41.24 is trading 1.2% above its estimated GF Value™ of $40.74. GuruFocus considers Universal Health Realtyome Trust to be Fairly Valued.

Key valuation signals for UHT:

  • Research & Development: $0.00 Mil
  • GF Value™: $40.74 vs. price of $41.24 (1.2% above fair value)
  • GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the UHT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universal Health Realtyome Trust Business Description

Industry Real EstateREITs
Other Exchanges WY8:Germany
Address 367 South Gulph Road, P.O. Box 61558, Universal Corporate Center, King of Prussia, PA, USA, 19406-0958
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.
75GF Score

Get the complete analysis for UHT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.24
Price
$40.74
GF Value